Because of its availability, ease of collection, and correlation with physiology and pathology, urine is an attractive source for clinical proteomics/peptidomics. However, the lack of comparable data sets from large cohorts has greatly hindered the development of clinical proteomics. Here, we report the establishment of a reproducible, high resolution method for peptidome analysis of naturally occurring human urinary peptides and proteins, ranging from 800 to 17,000 Da, using samples from 3,600 individuals analyzed by capillary electrophoresis coupled to MS. All processed data were deposited in an Structured Query Language (SQL) database. This database currently contains 5,010 relevant unique urinary peptides that serve as a pool of potential classifiers for diagnosis and monitoring of various diseases. As an example, by using this source of information, we were able to define urinary peptide biomarkers for chronic kidney diseases, allowing diagnosis of these diseases with high accuracy. Application of the chronic kidney disease-specific biomarker set to an independent test cohort in the subsequent replication phase resulted in 85.5% sensitivity and 100% specificity. These results indicate the potential usefulness of capillary electrophoresis coupled to MS for clinical applications in the analysis of naturally occurring urinary peptides.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease / Good, Dm; Zürbig, P; Argilés, A; Bauer, Hw; Behrens, G; Coon, Jj; Dakna, M; Decramer, S; Delles, C; Dominiczak, Af; Ehrich, Jh; Eitner, F; Fliser, D; Frommberger, M; Ganser, A; Girolami, Ma; Golovko, I; Gwinner, W; Haubitz, M; Herget Rosenthal, S; Jankowski, J; Jahn, H; Jerums, G; Julian, Ba; Kellmann, M; Kliem, V; Kolch, W; Krolewski, As; Luppi, Mario; Massy, Z; Melter, M; Neusüss, C; Novak, J; Peter, K; Rossing, K; Rupprecht, H; Schanstra, Jp; Schiffer, E; Stolzenburg, Ju; Tarnow, L; Theodorescu, D; Thongboonkerd, V; Vanholder, R; Weissinger, Em; Mischak, H; Schmitt Kopplin, P.. - In: MOLECULAR & CELLULAR PROTEOMICS. - ISSN 1535-9476. - STAMPA. - 9:(2010), pp. 2424-2437. [10.1074/mcp.M110.001917]

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

LUPPI, Mario;
2010

Abstract

Because of its availability, ease of collection, and correlation with physiology and pathology, urine is an attractive source for clinical proteomics/peptidomics. However, the lack of comparable data sets from large cohorts has greatly hindered the development of clinical proteomics. Here, we report the establishment of a reproducible, high resolution method for peptidome analysis of naturally occurring human urinary peptides and proteins, ranging from 800 to 17,000 Da, using samples from 3,600 individuals analyzed by capillary electrophoresis coupled to MS. All processed data were deposited in an Structured Query Language (SQL) database. This database currently contains 5,010 relevant unique urinary peptides that serve as a pool of potential classifiers for diagnosis and monitoring of various diseases. As an example, by using this source of information, we were able to define urinary peptide biomarkers for chronic kidney diseases, allowing diagnosis of these diseases with high accuracy. Application of the chronic kidney disease-specific biomarker set to an independent test cohort in the subsequent replication phase resulted in 85.5% sensitivity and 100% specificity. These results indicate the potential usefulness of capillary electrophoresis coupled to MS for clinical applications in the analysis of naturally occurring urinary peptides.
2010
9
2424
2437
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease / Good, Dm; Zürbig, P; Argilés, A; Bauer, Hw; Behrens, G; Coon, Jj; Dakna, M; Decramer, S; Delles, C; Dominiczak, Af; Ehrich, Jh; Eitner, F; Fliser, D; Frommberger, M; Ganser, A; Girolami, Ma; Golovko, I; Gwinner, W; Haubitz, M; Herget Rosenthal, S; Jankowski, J; Jahn, H; Jerums, G; Julian, Ba; Kellmann, M; Kliem, V; Kolch, W; Krolewski, As; Luppi, Mario; Massy, Z; Melter, M; Neusüss, C; Novak, J; Peter, K; Rossing, K; Rupprecht, H; Schanstra, Jp; Schiffer, E; Stolzenburg, Ju; Tarnow, L; Theodorescu, D; Thongboonkerd, V; Vanholder, R; Weissinger, Em; Mischak, H; Schmitt Kopplin, P.. - In: MOLECULAR & CELLULAR PROTEOMICS. - ISSN 1535-9476. - STAMPA. - 9:(2010), pp. 2424-2437. [10.1074/mcp.M110.001917]
Good, Dm; Zürbig, P; Argilés, A; Bauer, Hw; Behrens, G; Coon, Jj; Dakna, M; Decramer, S; Delles, C; Dominiczak, Af; Ehrich, Jh; Eitner, F; Fliser, D; Frommberger, M; Ganser, A; Girolami, Ma; Golovko, I; Gwinner, W; Haubitz, M; Herget Rosenthal, S; Jankowski, J; Jahn, H; Jerums, G; Julian, Ba; Kellmann, M; Kliem, V; Kolch, W; Krolewski, As; Luppi, Mario; Massy, Z; Melter, M; Neusüss, C; Novak, J; Peter, K; Rossing, K; Rupprecht, H; Schanstra, Jp; Schiffer, E; Stolzenburg, Ju; Tarnow, L; Theodorescu, D; Thongboonkerd, V; Vanholder, R; Weissinger, Em; Mischak, H; Schmitt Kopplin, P.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/704737
Citazioni
  • ???jsp.display-item.citation.pmc??? 189
  • Scopus 415
  • ???jsp.display-item.citation.isi??? 386
social impact